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Introduction: Little evidence is available on the natural course of osteoarthritis (OA) development and the
genes that protect and predispose individuals to it. This study was designed to compare strain-
dependent development of OA and its association with tissue regeneration in mice. Two recombinant
inbred lines LGXSM-6 and LGXSM-33 generated from LG/J and SM/J intercross were used. Previous
studies indicated that LGXSM-6 can regenerate both articular cartilage and ear hole punch while LGXSM-
33 cannot.
Methods: Transection of the medial meniscotibial ligament was performed on 10-week-old male mice to
induce OA. Cartilage damage was analyzed by histology and bone morphology was evaluated using
micro-computed tomography (CT). Ear punches were performed and evaluated by measurement of
residual hole diameter.
Results: Cartilage analysis showed that LGXSM-33 developed a signiﬁcantly higher grade of OA than
LGXSM-6. Bone analysis showed that LGXSM-33 had substantial subchondral bone and trabecular bone
thickening 8 weeks post-surgery, while LGXSM-6 showed bone loss over time. We also conﬁrmed that
LGXSM-6 can heal ear tissues signiﬁcantly better than LGXSM-33.
Conclusions: OA was found to be negatively correlated with the degree of tissue regeneration. LGXSM-
33, a poor healer of ear tissues (and articular cartilage), developed more OA compared to LGXSM-6,
which had better regenerative ability for ear tissues and articular cartilage. The phenotypic
differences observed here are due to genetic differences further suggesting that similar sets of
physiological processes and gene variants may mediate variation in OA development and tissue
regeneration.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a degenerative joint disease resulting in
articular cartilage ﬁbrillation and loss and is estimated to affect
70e90% of the population aged 60 years and older1. Knee OA is
thought to be dependent on multiple factors with mechanical
overload, obesity and trauma being themost prominent risk factors
(reviewed in Refs. (2,3)). The variation in OA susceptibility may be
due to a variation in responsiveness to these factors. Emerging
evidence indicates that 50e75% of variation in OA in humans is: L. J. Sandell, Department of
of Medicine at Barnes Jewish
233, St. Louis, MO 63110,
900.
andell).
s Research Society International. Pgenetic, however, little evidence is available on the genes that cause
and protect individuals from OA4e6. Evidence from genome-wide
association studies in humans has shown that OA appears to be
highly polygenic with multiple risk alleles conferring small effects6.
Clinical options for patients with cartilage defects and OA are
limited to symptomatic treatment, unless the patient is qualiﬁed
for osteotomy or total joint replacement. In recent years, treat-
ments that attempt to repair or restore the cartilage lesions have
been developed7,8 with limited success. Thus, the knowledge of the
genetic contribution to the susceptibility or protection from OA
would greatly contribute to our understanding of OA and would
provide not only potential treatment strategies but may also help
predict individuals who are at risk for developing OA.
Recently mouse experimental models of OA have demonstrated
that certain strains of mice are substantially protected from
developing OA9,10. For example, MRL/MpJ and DBA/1 mice areublished by Elsevier Ltd. All rights reserved.
S. Hashimoto et al. / Osteoarthritis and Cartilage 20 (2012) 562e571 563protected from post-traumatic arthritis and exhibited signiﬁcantly
less OA compared with C57BL/69. These protected strains also have
the ability to repair full-thickness articular cartilage defects10,11.
While these strains are outbred and therefore have different
genetic backgrounds, these results support the hypothesis that
speciﬁc regions of genome may contribute to the initiation and
progression of OA and tissue regeneration.
In order to begin to examine the genetic contribution to OA in
moredetail, recombinant inbred strainsof LG/J (healerof earwounds)
and SM/J (non-healer)micewere used12. The LG/J strain is the parent
line of the “super healer” MRL/MpJ strain13 and shares 75% of its
genome identical-by-descent13. We have recently used these
recombinant inbred lines to explore heritability for two traits: artic-
ular cartilage regeneration and ear wound healing14. We found that
these traits are statisticallyheritable anda strong correlationbetween
the phenotypes exists. Each recombinant inbred strain is a different
recombination of the parental genotypes, so we can expect their
outcomes to vary depending on the genetic differences that they
inherited from parental strains.
In order to evaluate OA progression in recombinant inbred lines,
destabilization of medial meniscus (DMM) model was used15. This
model provides several advantages over other models such as high
reproducibility and relatively slow progression of disease and
allows examination of changes in the entire joint over time.
In the disease process of OA, damage occurs not only to the
cartilage but also to other joint tissues such as the synovium,
ligaments, and bone. The boney changes, including osteophyte
formation and subchondral bone sclerosis are considered radio-
logical hallmarks of OA16. In addition, it has been shown that bone
mineral density in patients with the radiographic features of OA is
higher than in patients with normal joint morphology17. It was
hypothesized that osseous changes are considered necessary for the
progression of OA, however, whether the bone changes precede or
follow cartilage degeneration is unknown18. The correlation
between cartilage degeneration and bone changes from the onset of
OA to advanced stages is not well understood, and further investi-
gation of changes in bone architecture during OA development is
required. While not possible to study in humans particularly early
OA, in the present study, we were able to monitor osseous changes
over the time of induction and progression of OA in mice.
Here we present a study of OA development in selected LGXSM
recombinant inbred lines, LGXSM-6 and LGXSM-33 chosen because
they represent respectively good and poor extremes in ear hole
healing and articular cartilage regeneration14,19. The aim of this
study was to compare the strain-dependent changes in cartilage
and bone. This data combined with our previous data on genetics of
articular cartilage regeneration and ear wound healing14 allows
lines to be drawn between the ability to heal tissues and suscep-
tibility to OA.Table I
Scoring system used to evaluate cartilage degeneration for summed and maximum
OA score
Grade OA damage
0 NormalMaterials and methods
All studies were performed following approval from the Animal
Studies Committee of Washington University.0.5 Loss of staining without structural change
1 Roughened articular surface and small ﬁbrillations
2 Fibrillation down to the layer immediately below the superﬁcial layer
and some loss of surface lamina
3 Fibrillation/erosion to the calciﬁed cartilage extending to <25% of
the articular surface
4 Fibrillation/erosion to the calciﬁed cartilage extending to 25e50% of
the articular surface
5 Fibrillation/erosion to the calciﬁed cartilage extending to 50e75% of
the articular surface
6 Fibrillation/erosion to the calciﬁed cartilage extending to >75% of
the articular surfaceEar punch procedure
LGXSM-6 and LGXSM-33 mice were evaluated for their tissue
regeneration potential with ear punch closure. In 6-week-old mice,
2 mm holes were surgically produced in each ear as previously
described20. The diameters of the holes at 15 and 30 days after ear
punching were measured and recorded. All ear punches were
performed by the same person and read by two independent
observers.OA induction by DMM surgery
Only male mice were used for this study. Mice were anes-
thetized using an intraperitoneal injection of ketamine (100 mg/
kg), xylazine (20 mg/kg), and acepromazine (10 mg/kg) at 10 weeks
of age. DMM was induced in the right knee joint by transection of
the anterior attachment of medial meniscotibial ligament (MMTL)
described previously15. Brieﬂy, the joint capsule was opened with
an incision just medial to the patellar tendon and the MMTL was
sectioned with micro-surgical scissors. For control, surgery was
performed on left knee joints but the ligaments were left intact and
termed ‘sham joints’. All mice were weight-bearing following
recovery from anesthesia. Mice were sacriﬁced at 2, 4, and 8 weeks
after DMM surgery and subjected to a micro-computed tomog-
raphy (micro-CT) and histological analyses. The number of mice (N)
analyzed for each parameter and time points are indicated in the
graphs.Histological evaluation for cartilage degeneration
Knee joints were ﬁxed in 10% neutral buffered formalin, decal-
ciﬁed with 10% formic acid and embedded in parafﬁn. Coronal
histological sections were taken through the joint at 80 mm inter-
vals, stained with toluidine blue, and cartilage damage was scored
by two observers (SH, MFR) blinded to sample identity using
a published scoring system (Table I) by Glasson and colleagues21.
Histological scores were measured in four quadrants (medial
femoral condyle, medial tibial plateau, lateral femoral condyle, and
lateral tibial plateau) of both knee joints at all sectioned levels
(eight sections per knee), to obtain summed and maximum OA
scores. Summed score was calculated from all four quadrants for all
sections which represented whole joint changes. The maximum
score was the highest score within all sectioned levels for a given
knee.Micro-CT scanning and quantiﬁcation of bone morphometric
parameters
Prior to sectioning, knee joints were scanned using micro-CT
scanner (vivaCT 40, SCANCO MEDICAL) for analysis of
3-dimentional structure and bonemorphometric parameters. Two-
dimensional coronal images of the weight-bearing region of the
joint were generated by AMIRA system (Visage Imagings Inc., CA)
and used to measure the subchondral bone plate thickness for the
medial and lateral tibial plateau. The AMIRA system ﬁrst produces
3-dimentional images frommicro-CTdata and then reconstructs the
2-dimentional images. The outline of coronal images reﬂected
S. Hashimoto et al. / Osteoarthritis and Cartilage 20 (2012) 562e571564mineralized tissues of knee joints. In each region, eight points were
quantiﬁed from the top of mineralized articular surface to the
beginning of trabecular bone, and averagewas calculated [Fig. 4(A)].
In order to analyze subchondral bone changes, the epiphysis of the
tibia was chosen as the region of interest. The outline of the
epiphysis was manually selected and care was taken not to select
any outgrowing osteophyte. The following morphometric parame-
ters of the tibial subchondral plate were calculated for trabecular
compartments: bone volumeby tissue volume (BV/TV), i.e., the ratio
of trabecular bone volume over endocortical total volume, trabec-
ular thickness, and connectivity density index, that calculates the
number of trabecular connections per unit volume22.
Statistical analysis
Non-parametric tests were used for histological scores and bone
parameter differences between operated and sham knee joints.
Analysis of variance (ANOVA) was used to see strain and time point
differences. Differences were considered statistically signiﬁcant
when P was <0.05 and results are indicated as data points with
mean and upper and lower limits of 95% conﬁdence interval (CI)
unless indicated otherwise.
Results
Although little difference in gross appearance of LGXSM-6 and
LGXSM-33 mice, the average bodyweight of LGXSM-6 mice was
greater than LGXSM-33 mice (at 10 weeks of age, LGXSM-6:Fig. 1. Ear wound healing in LGXSM-6 and LGXSM-33 strains. Through-and-through ear pun
were created at 6 weeks of age using standard method. Gross appearance of ear hole in LGX
retained in LGXSM-33 strain indicates a failure of healing as compared to LGXSM-6 strain. A
punch showed that LGXSM-6 mice signiﬁcantly healed their ears at both day 15 and day 332.93 g 2.11; LGXSM-33: 25.57 g 2.14, P< 0.001, at 18 weeks
of age, LGXSM-6: 35.96 g 1.47; LGXSM-33: 30.06 g 2.69,
P¼ 0.002).
Ear punch closure
The LGXSM-6 mice were able to signiﬁcantly heal their ear
wounds [Fig. 1(A)] compared to LGXSM-33mice [Fig. 1(B)]. LGXSM-
6 mice showed a 45% reduction in ear hole diameter by 15 days
post-procedure and a 60% reduction by 30 days (P< 0.001).
In contrast, LGXSM-33 mice had only a 30% wound closure by 15
days and no further healing occurred up to 30 days (P¼ 0.40).
The average residual wound size after 30 days was 0.80 mm (95% CI
0.68e0.91) and 1.35 mm (95% CI 1.22e1.47) in LGXSM-6 and
LGXSM-33 mice, respectively [Fig. 1(C)].
Strain dependent induction of OA
Histological sections showed more cartilage degeneration after
induction of OA in LGXSM-33 than in LGXSM-6 mice at 8 weeks
post DMM surgery. Histological grading showed that LGXSM-33
mice demonstrated loss of proteoglycan staining with articular
ﬁbrillation at 2 weeks and loss of hyaline cartilage, proteoglycan
staining, and the lesions extended to calciﬁed cartilage at 4 and 8
weeks after surgery [Fig. 2(B)]. In contrast, LGXSM-6 mice showed
a focal loss of proteoglycan staining without severe cartilage loss at
all time points [Fig. 2(A)]. The extent of OA was determined by
scoring for speciﬁc parameters of OA and is presented as a summedcture wounds (2-mm in diameter) on external ears of LGXSM-6 and LGXSM-33 strains
SM-6 (A) and LGXSM-33 (B) mice after 30 days of ear punch is shown. A large ear hole
graphical representation of residual ear wound diameter (C) after 15 and 30 days of ear
0 compared to LGXSM-33 mice.
Fig. 2. Histological evaluation for OA development. Representative histological sections of LGXSM-6 (A) and LGXSM-33 (B) mice after 2, 4 and 8 weeks of DMM surgery (40) are
shown. Black arrows show cartilage damage in medial tibial plateau. MFC¼medial femoral condyle, LFC¼ lateral femoral condyle, MTP¼medial tibial plateau, LTP¼ lateral tibial
plateau, MM¼medial meniscus, LM¼ lateral meniscus.
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the eight sections) [Fig. 3(B)]. Histological scores demonstrated that
LGXSM-6 mice have a lower summed OA score (7.13; 95% CI
4.56e9.71) than LGXSM-33 mice (24.24; 95% CI 15.00e33.49) on 8
weeks after DMM surgery [Fig. 3(A)]. For the summed OA score,
LGXSM-33 mice developed OA in a time-dependent manner and to
a signiﬁcantly higher grade of OA than LGXSM-6mice after 8 weeks
of DMM surgery [P¼ 0.002, Fig. 3(A)]. For the maximum OA score,
LGXSM-33 mice had higher score than LGXSM-6 mice only in the
medial side of the joint [P¼ 0.003, Fig. 3(B)].Quantiﬁcation of bone morphometric parameters
Bone morphometric parameters were examined on the epiphysis
of tibia at 2, 4, and 8 weeks after surgery. Differences in subchondral
bone plate thickness were observed over time, between strains and
between medial and lateral compartments. LGXSM-33 showed
subchondral bone plate thinning at early time points (2 and
4 weeks), however the subchondral bone plate thickened signiﬁ-
cantly between 4 and 8 weeks on both medial and lateral tibial
plateau [medial: P¼ 0.001, lateral: P¼ 0.005, Fig. 4(B)], and at
borderline signiﬁcance compared to sham knee joints at 8 weeks
after surgery (medial: P¼ 0.046, lateral: P¼ 0.061). On the other
hand, LGXSM-6 mice showed thinning at all time points on both
sides but statistical signiﬁcant differences were seen between sham
and operated knees on medial side at 2 weeks (P¼ 0.026) and
4 weeks (P¼ 0.046) and on lateral side only at 4 weeks (P¼ 0.019)
time points [Fig. 4(C)].At all time points, LGXSM-6 mice showed signiﬁcantly lower
bone volume fraction (BV/TV) on the operated knee than sham
(2 weeks, P¼ 0.027; 4 weeks, P< 0.001; 8 weeks, P< 0.001), while
in LGXSM-33mice bone volume fraction decreased signiﬁcantly at 4
weeks (P¼ 0.030) compared to sham and then increased signiﬁ-
cantly at 8 weeks (P¼ 0.028) compared to at 4 weeks in operated
knee [Fig. 5(A)]. Trabecular bone thickness on the operated jointwas
less than the sham in LGXSM-6 mice at all time points but this
differencewas signiﬁcant only at 8weeks (P¼ 0.037), but in LGXSM-
33 mice trabecular thickness did not show signiﬁcant differences
between operated and sham joints over time. Although it decreased
initially at 4weeks, trabecular thickness was close to that of sham at
8 weeks (P¼ 0.032) [Fig. 5(B)]. The trabecular connective density
index, which calculates the number of trabecular bone connections,
showed that LGXSM-33 mice lost trabecular bone at 4 weeks
(P¼ 0.034) and gained slightly by 8weeks after surgery,while in the
LGXSM-6 mice signiﬁcant trabecular bone loss was observed at 4
weeks (P¼ 0.013) and 8 weeks (P¼ 0.049) [Fig. 5(C)].Discussion
Recent studies have convincingly demonstrated that LGXSM-6
and LGXSM-33 recombinant inbred lines from LG/J and SM/J
intercross differ signiﬁcantly in their capacity to heal through-and-
through ear wounds as well as knee articular cartilage14,19.
The most signiﬁcant ﬁnding of the present study is that these
strains also have different susceptibilities to OA development and
progression following transection of the MMTL (the DMM model).
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the ability to heal ear tissue: i.e., more tissue regeneration, less OA
and vice versa. These ﬁndings are in agreement with those of
others9,10,11, who have suggested that the ability to heal ear tissues
and ability to regenerate articular cartilage co-occur with resistance
to cartilage degeneration and protection from OA in mice.
Since it is generally thought that OA initiates when the cells are
stimulated to a higher level of metabolic activity with catabolic
effects out-striping anabolic effects23,24, the simplest interpretation
of our results would be that a greater anabolic capacity leads to
a better repair response and subsequently less OA development.
While these two strains of mice (LGXSM-6 and LGXSM-33) differ in
their phenotypic properties of healing, we studied the natural
course of development and progression of OA in these strains to see
how the changes in cartilage and bone develop over time. Thecartilage changes, represented by summed andmaximumOA score,
show that the LGXSM-33 strain has signiﬁcantly higher OA score in
operated knee compared to sham knee. Similarly this strain has
signiﬁcantly higher summed score in response to DMM at 4 and 8
weeks time points compared to strain LGXSM-6. If all joint carti-
lages were degraded, the summed OA score would be 192 (6-max
score 8 slides 4 quadrants). However, by convention, the OA
score is determined at 8 weeks after DMM surgery. The scores at
this time, range from 20 to 50 depending on the strain (common or
genetically engineered strains)15.
We observed bone loss following transection of MMTL in both
strains although LGXSM-6 consistently showed a greater bone loss
at each time point. We also found an increase in thickness of the
subchondral bone plate which occurs only concomitant with
signiﬁcant cartilage loss on the articulating surface. As the strain
AB
C
Fig. 4. Changes in subchondral bone thickness in LGXSM-33 and LGXSM-6 strains. Coronal sectional images were used for measurement of subchondral bone thickness in the
medial and lateral tibial plateau (A). Subchondral bone thickness on medial and lateral sides of LGXSM-33 after 2, 4, and 8 weeks of DMM surgery showed that there were signiﬁcant
differences in thickness of subchondral bone between sham and DMM on medial side after 8 weeks. Similarly, the DMM knees at 8 weeks from both medial and lateral sides were
signiﬁcantly higher than 2 and 4 weeks. In contrast, in LGXSM-6 mice the differences between subchondral bone thickness in sham and DMM knee varied signiﬁcantly at 2 and 4
weeks on medial side and only at 4 weeks on lateral side. The overall data from A and B show that LGXSM-33 develops more subchondral bone thickness than LGXSM-6. Filled
circles ¼ individual data points, Star ¼ mean value, hyphens ¼ upper and lower limits of 95% CI.
S. Hashimoto et al. / Osteoarthritis and Cartilage 20 (2012) 562e571 567that has less OA (LGXSM-6) does not demonstrate subchondral
bone plate thickening, it appears that the subchondral bone plate
thickening may be the result of cartilage loss.Bone morphologic changes are thought to be an important
factor in OA development. Micro-CT has been commonly applied to
study osseous changes in various animal models of OA25,26 as is
AB
C
Fig. 5. Trabecular bone parameters for LGXSM-6 and LGXSM-33 strains. All parameters were derived from trabecular bone of the entire epiphysis of DMM and sham in both strains.
Bone volume fraction (BV/TV) (A), trabecular thickness (B) and connectivity density index (C) are shown for LGXSM-6 and LGXSM-33 strains. Filled circles ¼ individual data points,
Star ¼ mean value, hyphens ¼ upper and lower limits of 95% CI.
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Table II
Summary of phenotypic characteristics of LGXSM-6 and LGXSM-33 strains
Property LGXSM-6 LGXSM-33
OA Mild Severe
Healing ear punch Yes No
Bone loss in early phase Yes No
Bone thickening in late phase No Yes
Cartilage repair Yes No
S. Hashimoto et al. / Osteoarthritis and Cartilage 20 (2012) 562e571 569evident by the following studies: (1) In a murine OA model where
overexpression of Smad3 induced cartilage degeneration, charac-
teristic bone morphometric phenotype was observed by micro-CT
including osteophyte formation, subchondral sclerosis, and
increased mineralization of meniscus27. (2) STR/ort mice, which
develop OA spontaneously, also showed subchondral sclerosis28.
(3) In a collagenase-injected murine model of OA, trabecular bone
was shown to become thinner and with loss of connections
between trabecular bones in the early phases of OA29. (4) The late
phase of OA development was examined in a DMM model of
ADAMTS-5 null mice wherein the removal of ADAMTS-5 gene
protected cartilage from degeneration30. Our studies also clearly
show that early bone loss is a reaction to the injury, and is followed
by subchondral bone thickening only when signiﬁcant cartilage
degeneration has occurred. These results are supported by the
numerous other studies where bone loss has been documented in
dogs31 and humans32e34 following a ligament injury. Subchondral
bone changes have also been reported as one of the important
morphologic phenotypes correlated with OA progression. For
example, a rat model of OA showed subchondral bone changes
following traumatic anterior cruciate ligament transection with
bone resorption at early time points and sclerosis in late phase35.
Similarly, in human OA patients, the femoral heads exhibited
trabecular bone thickening exclusively when the cartilage was
lost36 indicating that the subchondral bone changes are secondary
to cartilage loss rather than an independent event.
The baseline measurements of subchondral bone plate thick-
ness are different in these two strains. As such the baseline
measurement for subchondral bone thickness in LGXSM-33 strain
on both medial and lateral sides was less than LGXSM-6 strain at all
time points. Although there was an initial thinning of subchondral
bone in both strains in response to DMM surgery, the remarkable
differences in thickening of subchondral bone occurred at 8 weeks
only in LGXSM-33 strain. So the differences in thickness of sub-
chondral bone in LGXSM-33 in response to DMM surgery are likely
more important than the absolute baseline values. In other words,
it is LGXSM-33 that shows a trend for increased bone thickness at 8
weeks going beyond the baseline value and not LGXSM-6. Other
studies have demonstrated differences in subchondral bone thick-
ness betweenmouse strains, evenwith knock out of the ADAMTS-5
gene, the subchondral bone thickness is altered30. For the recombi-
nant inbred lines used here, one of us37 has studied bone charac-
teristics and found that LGXSM-6 has higher bone density than
LGXSM-33. Future studies will examine all the molecular mecha-
nisms that contribute to genetic differences in bone parameters.
Ear hole closure is very rare in mammals. MRL/MpJ strain was
the ﬁrst to be recognized to demonstrate an accelerated repair of all
tissues of the ear similar to an epimorphic regeneration seen in
lower vertebrates20 and this phenomenon has been shown to be
genetically controlled38. MRL/MpJ is also known to possess
an increased intrinsic resistance to post-traumatic OA9,11.
As mentioned above, one of the parent strains of LGXSM-6 and
LGXSM-33, LG/J, is also the parent line of MRL/MpJ. Thus, it is
tempting to believe that many of the same alleles present in MRL/
MpJ are also carried by LG/J and, in turn, by LGXSM-6 and LGXSM-
33. The different outcome of ear punch healing in each strain may
be informative regarding the regenerative ability in mammals.
Our study is the ﬁrst to demonstrate natural course of cartilage
and bone changes over time in genetically related strains with
different susceptibilities to OA. By comparing the differences in
bone and cartilage changes over time we have attempted to close
the gap between early and late changes in OA development. The
protection of LGXSM-6 from OA is most probably due to its
increased regenerative capacity even though this strain is slightly
larger than LGXSM-33. It is a commonly held belief that obesity isa risk factor for OA initiation and progression; however, the
LGXSM-6 strain is higher in body weight relative to LGXSM-33 but
is not obese. Both strains were fed a normal diet.
The differential phenotypes observed in this study can be attrib-
uted to a restricted set of genes according to the way they have been
inherited fromtheparental lines. Theuse of recombinant inbred lines
is very practical in that genotyping of each strain is needed only once
since each strain is isogenic and multiple phenotypes from each
strain can be obtained on each line, therefore different outcomes
from recombinant inbred lines are due to genetic differences.
Several of the same recombinant inbred lines of LG/J and SM/J were
used to identify speciﬁc regions of the genome that participate in
growth39, long bone length40, bone cross-sectional morphology and
strength37, obesity41, and response to dietary fat42,43.
In a companion study using the same strains of mice (LGXSM-6
and LGXSM-33) as well as other recombinant inbred strains and
common inbred strains, we demonstrated a positive correlation
between ear wound healing and articular cartilage regeneration14.
Thus the ability to regenerate ear wound and articular cartilage
appears to be protective for the development of OA. Taken together
these results strongly suggest that tissue regeneration and articular
cartilage regeneration may involve some of the same physiological
processes as protection from OA. The translational implication is
that individuals who are able to repair their articular cartilage may
be less susceptible to OA.
In summary, the natural course of OA development shows that
LGXSM-6mice are resistant to OA and demonstrate regeneration of
ear tissues as well as articular cartilage while LGXSM-33 mice
develop OA with subchondral bone thickening, and are unable to
substantially regenerate articular cartilage or ear tissues (Table II).
These results demonstrate that there are potentially related genetic
factors responsible for OA development, tissue regeneration, bone
response and cartilage regeneration in the LG/J by SM/J intercross
populations. These studies provide the proof of principle that
genetically different recombinant inbred lines also differ in their
susceptibility to OA providing the opportunity to identify speciﬁc
regions of genome that contribute to variation in OA development
and cartilage regeneration in the LGXSM intercross.
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